We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 332

Appeal of a decision to not bifurcate a s.8 action and infringement counterclaim dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • March 23 2016

The appeal of a Prothonotary's decision to refuse to bifurcate liability and quantification of an action comprising a claim pursuant to section 8 of


Supreme Court Leave to Appeal Granted
  • Borden Ladner Gervais LLP
  • Canada
  • March 16 2016

The Supreme Court has granted AstraZeneca leave to appeal in its application which asks the correct applicable standard for patent utility in Canada


Pleading amended to refer to prior art that may not be proven to be prior art
  • Borden Ladner Gervais LLP
  • Canada
  • March 16 2016

The Defendants sought to amend their Statement of Defence to include reference to a product referred to as prior art in support of their allegation


Motion challenging the listing of a patent on the patent register filed before the 2015 amendments to the PM(NOC) Regulations is decided on the basis of the old regulations
  • Borden Ladner Gervais LLP
  • Canada
  • March 16 2016

Apotex has successfully challenged the listing of a patent on the Patent Register pursuant to Paragraph 4(2)(a) of the PM(NOC) Regulations. The


Supreme Court Upcoming Leave to Appeal Decisions
  • Borden Ladner Gervais LLP
  • Canada
  • March 9 2016

The Supreme Court will announce the result of a leave application which asks the correct applicable standard for patent utility in Canada and whether


Compound patent held to be not soundly predicted for the level of promised utility found by the Court
  • Borden Ladner Gervais LLP
  • Canada
  • February 24 2016

The Federal Court has dismissed an application for prohibition concerning the drug ALIMTA. Although the parties joined issue on a significant number


S.53 of the Patent Act held Not to Apply when Public Servant Fails to Declare Status
  • Borden Ladner Gervais LLP
  • Canada
  • February 18 2016

In this case, Brown appealed a decision of the Federal Court, partially granting summary judgment in an invalidity claim, pursuant to s. 53 of the


Application to vary the ownership of patent granted where assignor inadvertently assigned rights to Gray Automotive Products, Inc., as opposed to Gray Automotive Products Co.
  • Borden Ladner Gervais LLP
  • Canada
  • February 4 2016

The Federal Court granted an application under section 52 of the Patent Act to vary all entries of the Patent Office relating to the ownership of


Standard of Review of Palpable and Overriding Error Not Applied in Appeal from Rule 51 Appeal
  • Borden Ladner Gervais LLP
  • Canada
  • January 27 2016

This is an appeal from the Federal Court's (FC) decision (2015 FC 797), which upheld the Prothonotary's decision allowing the generic Respondent's


Appeal relating to patent and industrial design dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • January 20 2016

The Supreme Court dismissed 1284897 Alberta Ltd.'s appeal from the judgment of the Federal Court of Appeal (2015 FCA 115